治疗人免疫缺损病毒(HIV)感染的一种新药似乎能延迟AIDS的发生。患AIDS 时,病人的T-细胞减少,用此药治疗能使病人的T-细胞群增加。 Ditiocarb(商品名为Imuthiol)是一种口服药物,其副作用似极小。该药是由法国 Institut Merieux公司生产。Lancet杂志(1988年24,Sept,第702页)报道一篇研究报告,包括80多名被HIV感染的病人。在开始的16周,一半病人接受Ditiocarb治疗,其他人接受安慰剂治疗。在第二个16周中改由安慰剂组用药。在开始16周中接 A new drug that treats human immunodeficiency virus (HIV) appears to delay the onset of AIDS. When suffering from AIDS, the patient’s T-cell reduction, with this drug treatment can make the patient’s T-cell population increased. Ditiocarb (trade name Imuthiol) is an oral medication with minimal side effects. The drug is produced by the French company Institut Merieux. Lancet (1988, 24, Sept, p. 702) reports a study that included more than 80 HIV-infected patients. In the first 16 weeks, half of the patients received Ditiocarb and the rest received placebo. In the second 16 weeks by the placebo group changed medication. In the beginning of 16 weeks in the next